Revofit™ System Evaluation on Residual Limb Pain in Amputee Patients
NCT ID: NCT04276714
Last Updated: 2022-07-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
1 participants
INTERVENTIONAL
2021-02-22
2021-03-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing New Prothesis PROPRIO-FOOT® Versus Usual Prothesis Tasks Tibial Amputees
NCT02501408
Contribution of Near-InfraRed Spectroscopy (NIRS) to the Evaluation of Healing After Amputation of the Leg
NCT02551484
Early Protected Full Weight-bearing vs. Partial Weight-bearing After Surgical Fixation of Unstable Ankle Fractures, Monitored With Bio-feedback Insoles.
NCT06023979
Outcome of a Cohort of Patients Fitted With a SYME Type Prosthesis in the Context of a Hindfoot Amputation With Distal Support
NCT06448260
Insole Sensor to Determine Optimal Limb Loading
NCT02170493
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adjustable socket
First week of the study is with adjustable socket
Socket without Revofit system
All the tests are evaluate during one week with the classical type of fittings
Socket with Revofit system
All the tests are evaluate during one week with the adjustable type of fittings (that is to say with Revofit system)
Classical socket
First week of the study is with classical socket
Socket without Revofit system
All the tests are evaluate during one week with the classical type of fittings
Socket with Revofit system
All the tests are evaluate during one week with the adjustable type of fittings (that is to say with Revofit system)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Socket without Revofit system
All the tests are evaluate during one week with the classical type of fittings
Socket with Revofit system
All the tests are evaluate during one week with the adjustable type of fittings (that is to say with Revofit system)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Above knee or below knee amputation (irrespective of etiology and time from amputation)
* Residual limb pain
* Prosthetic with classic fitting
* Fluctuations of residual limb requiring prosthetic adaptation (stump cotton sock, wedgning fitting …)
* Recipients or registered with a social security scheme
* Informed consent form signed beforehand
Exclusion Criteria
* Pregnant woman, nursing mother or parturiant
* Patient in detention by judicial or administrative decision
* Patient undergoing psychiatric compulsory care
* Patient in a health or social institution for purposes other than research
* Legally protected person
* Patient unable to express their consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Angers
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mickaël Dinomais
Role: PRINCIPAL_INVESTIGATOR
MD University hospital Angers
Yoann RONZI
Role: PRINCIPAL_INVESTIGATOR
MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
DIMONAIS
Angers, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
49RC19_0129
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.